Fat mass and obesity-associated ( FTO ) gene is essential for insulin secretion and β-cell function: In vitro studies using INS-1 cells and human pancreatic islets
Jalal Taneera,Anila Khalique,Sham Abdrabh,Abdul Khader Mohammed,Amal Bouzid,Waseem El-Huneidi,Yasser Bustanji,Nabil Sulaiman,Sarah Albasha,Maha Saber-Ayad,Mawieh Hamad
DOI: https://doi.org/10.1016/j.lfs.2024.122421
IF: 6.78
2024-01-19
Life Sciences
Abstract:Aims In this study, we investigated the role of the FTO gene in pancreatic β-cell biology and its association with type 2 diabetes (T2D). To address this issue, human pancreatic islets and rat INS-1 (832/13) cells were used to perform gene silencing, overexpression, and functional analysis of FTO expression; levels of FTO were also measured in serum samples obtained from diabetic and obese individuals. Results The findings revealed that FTO expression was reduced in islets from hyperglycemic/diabetic donors compared to normal donors. This reduction correlated with decreased INS and GLUT1 expression and increased PDX1, GCK, and SNAP25 expression. Silencing of Fto in INS-1 cells impaired insulin release and mitochondrial ATP production and increased apoptosis in pro-apoptotic cytokine-treated cells. However, glucose uptake and reactive oxygen species production rates remained unaffected. Downregulation of key β-cell genes was observed following Fto-silencing, while Glut2 and Gck were unaffected. RNA-seq analysis identified several dysregulated genes involved in metal ion binding, calcium ion binding, and protein serine/threonine kinase activity. Furthermore, our findings showed that Pdx1 or Mafa -silencing did not influence FTO protein expression. Overexpression of FTO in human islets promoted insulin secretion and upregulated INS, PDX1, MAFA, and GLUT1 expression. Serum FTO levels did not significantly differ between individuals with diabetes or obesity and their healthy counterparts. Conclusion These findings suggest that FTO plays a crucial role in β-cell survival, metabolism, and function and point to a potential therapeutic utility of FTO in T2D patients.
pharmacology & pharmacy,medicine, research & experimental